Literature DB >> 15329446

Protective role of liposome incorporated lipopolysaccharide antigen of Klebsiella pneumoniae in a rat model of lobar pneumonia.

Sanjay Chhibber1, Sunita Wadhwa, Vanashree Yadav.   

Abstract

In a lobar pneumonia model of Klebsiella pneumoniae, the immunoprotective role of free lipoploysaccharide (LPS) and liposome-incorporated LPS was studied. An alteration in the biological activity of the LPS molecule, in terms of its pyrogenicity and lethal toxicity, was observed on incorporation in the liposome. Compared at equal doses, liposome-incorporated LPS was found to be non-pyrogenic and 10 times less toxic than free LPS. Liposome-incorporated LPS was more effective in providing protection against K. pneumoniae induced lobar pneumonia in rats. The immunological mechanism underlying protection revealed involvement of both nonspecific and specific immune response. Alveolar macrophage activation was observed after 4 and 14 days of treatment with the free and liposome-entrapped forms of LPS, respectively. Specific immunity in terms of plaque-forming cells was seen with both forms of LPS. Delayed type hypersensitivity reaction was observed only with liposome-incorporated LPS. It is concluded that a non-toxic and immunogenic form of K. pneumoniae LPS can be obtained by incorporation of the native preparation into liposomes.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15329446

Source DB:  PubMed          Journal:  Jpn J Infect Dis        ISSN: 1344-6304            Impact factor:   1.362


  11 in total

1.  Comparison of the host responses to wild-type and cpsB mutant Klebsiella pneumoniae infections.

Authors:  Matthew S Lawlor; Scott A Handley; Virginia L Miller
Journal:  Infect Immun       Date:  2006-09       Impact factor: 3.441

2.  Progress towards the development of Klebsiella vaccines.

Authors:  Myeongjin Choi; Sharon M Tennant; Raphael Simon; Alan S Cross
Journal:  Expert Rev Vaccines       Date:  2019-06-28       Impact factor: 5.217

3.  Genetic requirements for Klebsiella pneumoniae-induced liver abscess in an oral infection model.

Authors:  Ya-Chun Tu; Min-Chi Lu; Ming-Ko Chiang; Shu-Ping Huang; Hwei-Ling Peng; Hwan-You Chang; Ming-Shiou Jan; Yi-Chyi Lai
Journal:  Infect Immun       Date:  2009-05-11       Impact factor: 3.441

4.  Coincorporation of LpxL1 and PagL mutant lipopolysaccharides into liposomes with Neisseria meningitidis opacity protein: influence on endotoxic and adjuvant activity.

Authors:  Jesús Arenas; Harry van Dijken; Betsy Kuipers; Hendrik Jan Hamstra; Jan Tommassen; Peter van der Ley
Journal:  Clin Vaccine Immunol       Date:  2010-01-27

5.  Inflammasome-activating nanoparticles as modular systems for optimizing vaccine efficacy.

Authors:  Stacey L Demento; Stephanie C Eisenbarth; Harald G Foellmer; Craig Platt; Michael J Caplan; W Mark Saltzman; Ira Mellman; Michel Ledizet; Erol Fikrig; Richard A Flavell; Tarek M Fahmy
Journal:  Vaccine       Date:  2009-04-03       Impact factor: 3.641

Review 6.  Prophylactic vaccine delivery systems against epidemic infectious diseases.

Authors:  Chao Pan; Hua Yue; Li Zhu; Guang-Hui Ma; Heng-Liang Wang
Journal:  Adv Drug Deliv Rev       Date:  2021-07-17       Impact factor: 17.873

7.  Liposome-based polymer complex as a novel adjuvant: enhancement of specific antibody production and isotype switch.

Authors:  Chia-Hung Chen; Yu-Ling Lin; Yen-Ku Liu; Pei-Juin He; Ching-Min Lin; Yi-Han Chiu; Chang-Jer Wu; Tian-Lu Cheng; Shih-Jen Liu; Kuang-Wen Liao
Journal:  Int J Nanomedicine       Date:  2012-02-03

8.  Production of a Promising Biosynthetic Self-Assembled Nanoconjugate Vaccine against Klebsiella Pneumoniae Serotype O2 in a General Escherichia Coli Host.

Authors:  Zhehui Peng; Jun Wu; Kangfeng Wang; Xin Li; Peng Sun; Lulu Zhang; Jing Huang; Yan Liu; Xiaoting Hua; Yunsong Yu; Chao Pan; Hengliang Wang; Li Zhu
Journal:  Adv Sci (Weinh)       Date:  2021-05-24       Impact factor: 16.806

Review 9.  Development of a new trend conjugate vaccine for the prevention of Klebsiella pneumoniae.

Authors:  Tarek A Ahmad; Medhat Haroun; Ahmad A Hussein; El Sayed H El Ashry; Laila H El-Sayed
Journal:  Infect Dis Rep       Date:  2012-07-23

Review 10.  Potential targets for next generation antimicrobial glycoconjugate vaccines.

Authors:  Francesca Micoli; Paolo Costantino; Roberto Adamo
Journal:  FEMS Microbiol Rev       Date:  2018-05-01       Impact factor: 16.408

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.